Tag Archives: drug molecules

CRISPR and other new technologies are opening the doors to drug development, but which diseases are prioritized? Depends on money and science

Prescription drugs and vaccines have revolutionized healthcare, significantly reducing deaths from disease and improving quality of life worldwide. So how do researchers, universities, hospitals, and the pharmaceutical industry decide which diseases to try to develop drugs for? Working as director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of Connecticut School… Read More »

CRISPR and other new technologies are opening the doors to drug development, but which diseases are prioritized? Depends on money and science

Emerging social problems or opportunities can significantly impact the funding available for the development of drugs for specific diseases. When COVID-19 ravaged the world, funding from Operation Warp Speed ​​led to vaccine development in record time. Public awareness campaigns, such as the ALS ice bucket challenge, can also directly raise money for research. This viral… Read More »